Product Information

PIOGLITAZONE-METFORMIN 15-850 is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2083 per EA under NDC 57237021860. Its NADAC has been published 526 times since Oct 19, 2016.

FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE-METFORMIN 15-850

Pioglitazone Hydrochloride and Metformin Hydrochloride
$0.2083per EA

Strength

850; 15 mg/1; mg/1

NDC

57237021860

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200823

FDA Approved

2/13/2013

TE Code

AB

On Market Since

2/13/2013

Pharmacological Classes

Biguanide
Biguanides
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-METFORMIN 15-850 has been published 526 times since Oct 19, 2016, and over the history we have for it it has declined 88.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2083 per EA
All-time high$1.7583 (Nov 16, 2016)
All-time low$0.2083 (Oct 21, 2026)
52-week high$0.3035
52-week low$0.2083
Median price$0.5612
Average price$0.5993
Largest weekly change-54.8% (Sep 20, 2023)
Weeks tracked526
Tracking sinceOct 19, 2016

Price History

1W

0.0%

1M

-12.9%

3M

-31.4%

6M

-25.2%

1Y

-27.7%

3Y

-31.1%

5Y

-64.2%

All

-88.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-METFORMIN 15-850?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-850, manufactured by Rising Pharma Holdings Inc., is $0.2083 per EA (NDC 57237021860), effective Nov 11, 2026.

How has the price of PIOGLITAZONE-METFORMIN 15-850 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has declined 88.2%. It has been tracked across 526 weekly CMS publications since Oct 19, 2016.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-850?

Since Oct 19, 2016, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has ranged from a low of $0.2083 (Oct 21, 2026) to a high of $1.7583 (Nov 16, 2016), with a median of $0.5612 per EA.

Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-850?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE-METFORMIN 15-850 in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE-METFORMIN 15-850?

PIOGLITAZONE-METFORMIN 15-850 (NDC 57237021860) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.